Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

HC Wainwright & Co. Downgrades Reneo Pharmaceuticals to Neutral, Lowers Price Target to $1.5

Author: Benzinga Newsdesk | December 15, 2023 06:30am
HC Wainwright & Co. analyst Mitchell Kapoor downgrades Reneo Pharmaceuticals (NASDAQ:RPHM) from Buy to Neutral and lowers the price target from $30 to $1.5.

Posted In: RPHM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist